126 related articles for article (PubMed ID: 2460847)
1. Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment.
Brunello N; Riva M; Rovescalli AC; Galimberti R; Racagni G
Pharmacol Toxicol; 1988 Sep; 63(3):150-5. PubMed ID: 2460847
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of chronic desipramine and amitriptyline treatment on rat brain adrenergic and serotonergic receptors.
Tang SW; Seeman P; Kwan S
Psychiatry Res; 1981 Apr; 4(2):129-38. PubMed ID: 6939004
[TBL] [Abstract][Full Text] [Related]
3. Effect of different photoperiod exposure on [3H]imipramine binding and serotonin uptake in the rat brain.
Rovescalli AC; Brunello N; Riva M; Galimberti R; Racagni G
J Neurochem; 1989 Feb; 52(2):507-14. PubMed ID: 2463336
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.
Hrdina PD; Foy B; Hepner A; Summers RJ
J Pharmacol Exp Ther; 1990 Jan; 252(1):410-8. PubMed ID: 2137177
[TBL] [Abstract][Full Text] [Related]
5. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
Gulati A; Arora RC; Crayton J
Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
[TBL] [Abstract][Full Text] [Related]
6. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
Dewar KM; Reader TA; Grondin L; Descarries L
Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
[TBL] [Abstract][Full Text] [Related]
7. [Specific inhibitory action of a novel antidepressant paroxetine on 5-HT uptake].
Tanigaki N; Manno K; Sugihara K; Miki N; Ichida S; Yoshida H
Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):175-80. PubMed ID: 3038714
[TBL] [Abstract][Full Text] [Related]
8. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
Dewar KM; Grondin L; Carli M; Lima L; Reader TA
J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
[TBL] [Abstract][Full Text] [Related]
9. Characterization of [3H]paroxetine binding in rat brain.
Marcusson JO; Bergström M; Eriksson K; Ross SB
J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
[TBL] [Abstract][Full Text] [Related]
10. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
Nash JF; Arora RC; Schreiber MA; Meltzer HY
Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
[TBL] [Abstract][Full Text] [Related]
11. Unaltered 5-HT- and desipramine-sensitive [3H]imipramine binding and [3H]5-HT uptake in rat brain after chronic imipramine and norzimeldine treatment.
Marcusson J; Bäckström IT; Ross SB
Psychopharmacology (Berl); 1988; 94(2):193-6. PubMed ID: 2965397
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant binding: implications for the mode of action and the biology of depression.
Hrdina PD
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):457-62. PubMed ID: 6320297
[TBL] [Abstract][Full Text] [Related]
13. Sodium-dependent [3H]imipramine binding in rat hippocampus and its relationship to serotonin uptake.
Hrdina PD
Can J Physiol Pharmacol; 1987 Dec; 65(12):2422-7. PubMed ID: 2452679
[TBL] [Abstract][Full Text] [Related]
14. Effects of concurrent subchronic treatments with desmethylimipramine and propranolol on beta-adrenergic and serotonin2 receptors in rat brain.
Mason GA; Walker CH; Little KY
Psychopharmacology (Berl); 1993; 110(1-2):110-4. PubMed ID: 7870868
[TBL] [Abstract][Full Text] [Related]
15. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex.
Torda T; Murgas K; Cechova E; Kiss A; Saavedra JM
Brain Res; 1990 Sep; 527(2):198-203. PubMed ID: 1701336
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
Riva MA; Creese I
Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051
[TBL] [Abstract][Full Text] [Related]
18. Some effects of chronic antidepressant treatments on rat brain monoaminergic systems.
Sugrue MF
J Neural Transm; 1983; 57(4):281-95. PubMed ID: 6197507
[TBL] [Abstract][Full Text] [Related]
19. Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants on beta-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortex.
Hall H; Ross SB; Sällemark M
J Neural Transm; 1984; 59(1):9-23. PubMed ID: 6325593
[TBL] [Abstract][Full Text] [Related]
20. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Eison AS; Eison MS; Yocca FD; Gianutsos G
Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
